Aligos Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.54
|
|
Average Rating
|
3.25
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.58
|
-0.44
|
0.14
|
24.14%
|
|
2022-06-30
|
-0.67
|
-0.47
|
0.20
|
29.85%
|
|
2022-03-31
|
-0.73
|
-0.84
|
-0.11
|
-15.07%
|
|
2021-12-31
|
-0.83
|
-0.89
|
-0.06
|
-7.23%
|
|
2021-09-30
|
-0.81
|
-0.78
|
0.03
|
3.70%
|
|
2021-06-30
|
-0.81
|
-0.79
|
0.02
|
2.47%
|
|
2021-03-31
|
-0.90
|
-0.74
|
0.16
|
17.78%
|
|
2020-12-31
|
-0.82
|
-1.09
|
-0.27
|
-32.93%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.75
|
|
2021-12-31
|
-3.20
|
|
2020-12-31
|
-13.03
|